Monitoring of Anti-TFPI in Hemophilia

RecruitingOBSERVATIONAL
Enrollment

11

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
HemophiliaRebalancing AgentsProphylaxis
Interventions
BIOLOGICAL

blood sampling

One-time peripheral blood draw (10.8 mL total, 4 citrated tubes) collected during a routine clinical visit for thrombin generation testing on platelet-rich and platelet-poor plasma. No additional medical procedures or treatments are involved in the study.

Trial Locations (2)

69677

RECRUITING

Groupement hospitalier Est Hôpital Cardilogique Service d'hémostase clinique, Bron

75015

NOT_YET_RECRUITING

Centre de Référence Hémophilie et autres déficits rares en protéine de la coagulationCentre de Traitemendes Hémophiles F. Josso, Paris

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT07101926 - Monitoring of Anti-TFPI in Hemophilia | Biotech Hunter | Biotech Hunter